Inceptionr LLC Acquires New Shares in The Cooper Companies, Inc. $COO

Inceptionr LLC bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 27,900 shares of the medical device company’s stock, valued at approximately $1,995,000. Cooper Companies comprises 0.5% of Inceptionr LLC’s portfolio, making the stock its 16th largest position.

Several other institutional investors have also recently bought and sold shares of the business. Wellington Management Group LLP boosted its stake in shares of Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares in the last quarter. Generation Investment Management LLP acquired a new position in Cooper Companies during the 4th quarter worth approximately $233,539,000. Diamond Hill Capital Management Inc. lifted its stake in Cooper Companies by 479.6% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock valued at $269,471,000 after purchasing an additional 2,720,594 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Cooper Companies by 58.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after purchasing an additional 2,231,568 shares during the last quarter. Finally, Franklin Resources Inc. boosted its position in Cooper Companies by 108.2% in the fourth quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock valued at $329,646,000 after buying an additional 2,089,763 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on COO. Piper Sandler set a $86.00 target price on shares of Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research note on Sunday, June 21st. Robert W. Baird cut their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. Stifel Nicolaus reduced their price objective on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Finally, Wells Fargo & Company reaffirmed a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Cooper Companies currently has an average rating of “Hold” and a consensus price target of $81.85.

Cooper Companies Trading Down 0.4%

COO opened at $70.23 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The company’s 50 day moving average price is $67.13 and its two-hundred day moving average price is $72.21. The firm has a market capitalization of $13.70 billion, a price-to-earnings ratio of 59.52, a PEG ratio of 1.84 and a beta of 0.84.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the previous year, the business earned $0.96 earnings per share. Cooper Companies’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, research analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.